Search Results 1541-1550 of 17839 for Substance+dependence
The purpose of this study is to assess a new drug to decrease liver fat in subjects with Non-Alcoholic Steatohepatitis or Non-Alcoholic Fatty Liver Disease.
Venetoclax is FDA approved for the treatment of CLL and SLL. The drug combination of acalabrutinib, durvalumab, and venetoclax is experimental and isn't ...
... drug intervention. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health ...
Histologic response to steroids in eosinophilic esophagitis is dependent on delivery compound. Dis Esophagus. 2022 Dec 31; 36 (1) View PubMed; Schupack DA ...
By condition, treatment or drug name. Search tips. Rem-422, an MYB mRNA Degrader, in Patients With Relapsed/Refractory AML or Higher-Risk MDS. Print details.
By condition, treatment or drug name. Search tips. Effects of Background Composition, Tilt, and Rotation on Accuracy of the Subjective Visual Vertical. Print ...
... dependent breast tumor regression. Oncotarget. 2025 May 20; 16:379-381. View PubMed; Makovicka JL, Moore ML, Pollock JR, Rodriguez MJ, Shaha JS, Haglin JM ...
By condition, treatment or drug name ... Prevalence of abnormal suppression was dependent on three factors: patient age, goitre type and estimated thyroid weight.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.